These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 9186363)

  • 1. Cell kinetic in epithelium and stroma of benign prostatic hyperplasia.
    Claus S; Berges R; Senge T; Schulze H
    J Urol; 1997 Jul; 158(1):217-21. PubMed ID: 9186363
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Effect of hypertension on cell proliferation and apoptosis in benign prostatic hyperplasia].
    Li PJ; Zhang XH; Guo LJ; Na YQ
    Zhonghua Nan Ke Xue; 2005 Feb; 11(2):94-7. PubMed ID: 15755024
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Apoptosis profiles in benign prostatic hyperplasia: close associations of cell kinetics with percent area density of histologic composition.
    Zhang X; Zhang Q; Zhang Z; Na Y; Guo Y
    Urology; 2006 Oct; 68(4):905-10. PubMed ID: 17070390
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Biologic feature of prostatic hyperplasia developed in spontaneously hypertensive rats.
    Zhang X; Na Y; Guo Y
    Urology; 2004 May; 63(5):983-8. PubMed ID: 15135004
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Alpha 1-adrenoceptor antagonists terazosin and doxazosin induce prostate apoptosis without affecting cell proliferation in patients with benign prostatic hyperplasia.
    Chon JK; Borkowski A; Partin AW; Isaacs JT; Jacobs SC; Kyprianou N
    J Urol; 1999 Jun; 161(6):2002-8. PubMed ID: 10332490
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Proliferation and apoptosis status in benign prostatic hyperplasia].
    Deng F; Gu F; Xia T
    Zhonghua Wai Ke Za Zhi; 1996 Oct; 34(10):620-2. PubMed ID: 9590740
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression of survivin and apoptotic biomarkers in benign prostatic hyperplasia.
    Shariat SF; Ashfaq R; Roehrborn CG; Slawin KM; Lotan Y
    J Urol; 2005 Nov; 174(5):2046-50. PubMed ID: 16217391
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Basal cell hyperplasia in the peripheral zone of the prostate.
    Thorson P; Swanson PE; Vollmer RT; Humphrey PA
    Mod Pathol; 2003 Jun; 16(6):598-606. PubMed ID: 12808066
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Cell apoptosis and proliferation in the transition and peripheral zones in human prostate].
    Sun HB; Xia SJ
    Zhonghua Nan Ke Xue; 2007 Feb; 13(2):110-3. PubMed ID: 17345763
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chronic inflammation in benign prostate hyperplasia is associated with focal upregulation of cyclooxygenase-2, Bcl-2, and cell proliferation in the glandular epithelium.
    Wang W; Bergh A; Damber JE
    Prostate; 2004 Sep; 61(1):60-72. PubMed ID: 15287094
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Apoptotic regression of prostatic tissue induced by short-term doxazosin treatment in benign prostatic hyperplasia.
    Türkeri LN; Ozyürek M; Ersev D; Akdaş A
    Arch Esp Urol; 2001 Mar; 54(2):191-6. PubMed ID: 11341128
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunohistochemical comparative analysis of transforming growth factor alpha, epidermal growth factor, and epidermal growth factor receptor in normal, hyperplastic and neoplastic human prostates.
    De Miguel P; Royuela ; Bethencourt R; Ruiz A; Fraile B; Paniagua R
    Cytokine; 1999 Sep; 11(9):722-7. PubMed ID: 10479409
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunohistochemical analysis of the IL-6 family of cytokines and their receptors in benign, hyperplasic, and malignant human prostate.
    Royuela M; Ricote M; Parsons MS; García-Tuñón I; Paniagua R; de Miguel MP
    J Pathol; 2004 Jan; 202(1):41-9. PubMed ID: 14694520
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Relationship between prostatic atrophy and apoptosis in the canine spontaneous benign prostatic hyperplasia (BPH) following chlormadinone acetate (CMA).
    Murakoshi M; Ikeda R; Fukui N; Nakayama T
    Tokai J Exp Clin Med; 2001 Jul; 26(2):71-5. PubMed ID: 11806444
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Protease-activated receptor-1 upregulates fibroblast growth factor 7 in stroma of benign prostatic hyperplasia.
    Wang W; Zhang X; Mize GJ; Takayama TK
    Prostate; 2008 Jul; 68(10):1064-75. PubMed ID: 18386288
    [TBL] [Abstract][Full Text] [Related]  

  • 16. New histopathological experimental model for benign prostatic hyperplasia: stromal hyperplasia in rats.
    Mori F; Oda N; Sakuragi M; Sakakibara F; Kiniwa M; Miyoshi K
    J Urol; 2009 Feb; 181(2):890-8. PubMed ID: 19095262
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Apoptotic versus proliferative activities in human benign prostatic hyperplasia.
    Kyprianou N; Tu H; Jacobs SC
    Hum Pathol; 1996 Jul; 27(7):668-75. PubMed ID: 8698310
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Perineural invasion of prostate carcinoma cells is associated with reduced apoptotic index.
    Yang G; Wheeler TM; Kattan MW; Scardino PT; Thompson TC
    Cancer; 1996 Sep; 78(6):1267-71. PubMed ID: 8826950
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Histopathologic characterization of hereditary benign prostatic hyperplasia.
    Doehring CB; Sanda MG; Partin AW; Sauvageot J; Juo H; Beaty TH; Epstein JI; Hill G; Walsh PC
    Urology; 1996 Oct; 48(4):650-3. PubMed ID: 8886078
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of finasteride (Proscar) on the proliferation of cultured epithelial and stromal cells from normal and hyperplastic human prostates.
    Lobaccaro JM; Boudon C; Lechevallier E; Mottet N; Rebillard X; Lumbroso S; Gibelin B; Sultan C
    Cell Mol Biol (Noisy-le-grand); 1996 Jun; 42(4):511-8. PubMed ID: 8828906
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.